300+ investors in your industry, stage, and region Get
Any industry
Google
Biotech
Proptech
Climate
Community
Impact
Gaming
Artificial Intelligence
EdTech
Sustainability
Clean Energy
Retail
Finance
Digital Media
Local
Enterprise Software
Travel
Platforms
Recruiting
Social
Wine and Spirits
Mobile Apps
InsurTech
Oil and Gas
Theatre
Non Profit
Social Impact
Celebrity
Cryptocurrency
SaaS
Film
Crowdfunding
Venture Capital
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Payments
Renewable Energy
Organic Food
Email
Financial Services
Manufacturing
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Media (Entertainment)
Facebook
Blockchain
Beauty
Real Estate
Life Science
B2B
Publishing
Food and Beverage
Social Network
Web3
Big Data
Video Games
Education
Medical
Wellness
Medical Device
Art
Social Media
Android
Internet
Franchise
Music
Mobile
Legal
Construction
Automotive
Sports
eSports
Hospitality
Cannabis
Mobile Advertising
Biotechnology
FinTech
Consumer
Hardware
Transportation
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Algeria
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Nigeria
Jamaica
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Romania
Bangladesh
Kenya
Kazakhstan
Cayman Islands
Cambodia
Oman
Colombia
Cameroon
Guatemala
Seychelles
Ireland
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
United States
New Zealand
Cyprus
India
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in United Kingdom (June 2026)

The most active venture capital funds investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Parkwalk Advisors
VC Fund
17 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $982k–$46M
UK Innovation & Science Seed Fund
VC Fund
14 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $393k–$14M
Oxford Science Enterprises
VC Fund
14 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
SOSV
VC Fund
13 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Development Bank of Wales
VC Fund
10 United Kingdom, Australia, United States Seed, Debt Financing Software, Health Care, Biotechnology $18k–$3.7M
Sofinnova Partners
VC Fund
8 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$102M
24 Haymarket
VC Fund
7 United Kingdom, United States Seed, Series A Health Care, Software, Information Technology $714k–$16M
GM&C Life Sciences Fund
VC Fund
7 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $65k–$4.1M
Scottish Enterprise
VC Fund
7 United Kingdom, United States, Japan Seed, Grant Biotechnology, Software, Health Care $104k–$4.1M
Syncona Partners LLP
VC Fund
7 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.8M–$131M
IQ Capital
VC Fund
7 United Kingdom, United States, Germany Seed, Series A Software, Artificial Intelligence, Machine Learning $1.3M–$19M
Future Planet Capital
VC Fund
6 United Kingdom, United States, Canada Seed, Convertible Note Biotechnology, Health Care, Software $897k–$7.9M
Archangels
VC Fund
6 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $1.3M–$8.3M
Newable Private Investing
VC Fund
6 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $196k–$5.2M
Angels in MedCity
VC Fund
6 United Kingdom, United States Seed, Angel Health Care, Biotechnology, Medical $458k–$880k
Kindred Capital
VC Fund
6 United Kingdom, United States, Germany Seed, Series A, Series B Software, Biotechnology, Health Care $1.5M–$73M
Selvedge Venture
VC Fund
6 United Kingdom, Singapore Seed, Pre-Seed, Series A Health Care, Biotechnology, Life Science $1.1M–$30M
Deepbridge Capital
VC Fund
5 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $152k–$15M
APEX Ventures
VC Fund
5 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$28M
Epidarex Capital
VC Fund
5 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $531k–$55M
Scottish Investment Bank
VC Fund
5 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Health Care $327k–$7M
Cambridge Innovation Capital
VC Fund
4 United Kingdom, United States, Ireland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$73M
AlbionVC
VC Fund
4 United Kingdom, United States, France Series A, Seed Software, Information Technology, Health Care $2.2M–$20M
O2h Ventures
VC Fund
4 United Kingdom, Hungary Seed, Series A Biotechnology, Health Care, Pharmaceutical $655k–$26M
Angels 5K
VC Fund
4 United Kingdom Seed, Angel Biotechnology, Software, Medical $79k–$1.3M
Techstart Ventures
VC Fund
4 United Kingdom, Ireland, United States Seed, Pre-Seed Software, Information Technology, Health Care $183k–$3.5M
IP Group
VC Fund
4 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $393k–$23M
Playfair Capital
VC Fund
4 United Kingdom, United States, France Seed, Series A, Pre-Seed Software, Artificial Intelligence, E-Commerce $700k–$20M
Formic Ventures
VC Fund
4 United States, United Kingdom, Hong Kong Seed, Series A Biotechnology, Health Care, Biopharma $1.3M–$61M
Dementia Discovery Fund
VC Fund
4 United States, United Kingdom, Israel Seed, Series A Biotechnology, Health Care, Therapeutics $5.9M–$77M
SR One
VC Fund
4 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.7M–$115M
Maven Capital Partners
VC Fund
4 United Kingdom, United States, Germany Seed, Series A Software, Information Technology, SaaS $655k–$25M
11.2 Capital
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Software, Information Technology, Biotechnology $1M–$53M
Verve Ventures
VC Fund
4 Switzerland, France, Germany Series A, Seed, Series B Health Care, Software, Biotechnology $1.2M–$45M
Delin Ventures
VC Fund
4 United Kingdom, Germany, Hungary Seed, Series A, Series B Software, Biotechnology, Information Technology $1.3M–$100M
Northstar Ventures
VC Fund
4 United Kingdom, United States, Indonesia Seed, Series A Software, Health Care, E-Commerce $39k–$9.7M
Octopus Ventures
VC Fund
4 United Kingdom, United States, Germany Series A, Seed, Series B Software, Health Care, Information Technology $1.9M–$46M
Mercia Fund Managers
VC Fund
4 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $196k–$14M
Oxford Capital
VC Fund
4 United Kingdom, United States, France Seed, Series A Software, Health Care, Biotechnology
Google Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1M–$105M
SIS Ventures
VC Fund
3 United Kingdom Seed, Series A Biotechnology, Health Care, Medical $1M–$19M
Molten Ventures
VC Fund
3 United Kingdom, United States, Germany Series A, Series B Software, Information Technology, Financial Services $3.2M–$60M
Calculus Capital
VC Fund
3 United Kingdom, United States, Ireland Series A, Seed Biotechnology, Software, Medical $2M–$18M
Cambridge Angels group
VC Fund
3 United Kingdom, United States, Estonia Seed, Series A Software, Health Care, Biotechnology $270k–$9.5M
Nina Capital
VC Fund
3 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Medical
HG Ventures
VC Fund
3 United States, United Kingdom, Germany Seed, Series A, Series B Manufacturing, Biotechnology, Renewable Energy
Ada Ventures
VC Fund
3 United Kingdom, Ireland Seed, Pre-Seed Health Care, Marketplace, Software
Discovery Park
VC Fund
3 United Kingdom Pre-Seed, Seed Life Science, Biotechnology, Biopharma
R42 Group
VC Fund
3 United Kingdom, United States, Austria Seed, Pre-Seed Biotechnology, Health Care, Information Technology
Catapult Ventures
VC Fund
3 United Kingdom, United States, Israel Seed, Series A Health Care, Biotechnology, Medical
Access all 492 VC funds in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 17 investments in United Kingdom Life Science startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 255
  • Round size: Seed $982k–$4.7M; Series A $1.6M–$13M; Series B $2M–$46M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Nozzle.ai — Award-winning Amazon analytics tools designed to provide FBA Amazon Sellers with unique customer insights. Try for Free.
  • Phasecraft — Using disruptive theory to unlock the power of quantum computing
  • Echion Technologies — Echion Technologies is a spinout from the University of Cambridge Engineering Department, using proprietary battery active materials to develop next-generation Li-ion batteries.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 14 investments in United Kingdom Life Science startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 130
  • Round size: Seed $393k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Presymptom Health — Enabling Early Diagnosis for better infection & sepsis care. With faster, more accurate testing. Presymptom Health is a medtech company developing a portfolio of patented diagnostic tests that are both faster and more reliable than those available today. Accelerate diagnosis. Address antimicrobial resistance.
  • Pencil Biosciences — Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to overcome the limitations of current technologies.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 14 investments in United Kingdom Life Science startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 161
  • Round size: Seed $1.3M–$10M; Series A $5M–$46M; Series B $8.5M–$168M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $327M in 2022

Portfolio highlights

  • Mode Labs — Mode Labs provide robust, continuous, and remote real-time chemical sensors.
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
  • Pepgen — PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides,and they are advancing novel conjugate therapeutics to the clinic.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 13 investments in United Kingdom Life Science startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 10 investments in United Kingdom Life Science startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 211
  • Round size: Seed $327k–$3.7M; Debt Financing $18k–$2M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2018

Portfolio highlights

  • Forth — Forth are a group of clinical and digital experts who are passionate about healthcare. They’re part of a new breed of digital healthcare companies who are transforming people’s relationship with their health by using technology to give them more information and help them gain greater control.
  • enModus — Experience the thrill of competing against other players in online casino tournaments! These events offer a unique opportunity to showcase your skills and
  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 8 investments in United Kingdom Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 298
  • Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $714k–$3.8M; Series A $1.6M–$16M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Angoka — ANGOKA is an IoT security company focused on protecting M2M communications for Smart Cities and Mobility. Headquartered in Belfast, with offices in London and The Hague, ANGOKA offers solutions that protect devices’ identities. With an increase of inherently insecure networks coming online with the boom of IoT, ANGOKA’s solutions safeguard criticalmachine-to-machine communication integrity and data provenance, creating trusted connections, even in untrustworthy networks.ANGOKA is the only cybersecurity company to win a place on Zenzic’s CAM Scale-Up Programme, delivered in partnership with Plug and Play. ANGOKA was also the first NI start-up to be selected for NCSC’s Cyber Accelerator, who reviewed and assessed ANGOKA’s technology. ANGOKA is also an alumnus of Seraphim Space Camp, Yes!Delft and TechNation Cyber 2.0. Finally, ANGOKA has been awarded several Innovate UK R&D projects, which focus on securing quantum communications (led by BT) and two drone projects.
  • CyberOwl — CyberOwl develops an innovative early warning system for attacks through real-time monitoring of high-value targets for malicious behavior. The technology, based on research shortlisted for the Lloyd’s Science of Risk Prize 2015, is aimed at addressing the challenges of increasingly anonymous and persistent threats to rapidly-expanding globalnetworks, particularly in the wake of Smart Cities and the Internet of Things. The system raises early warning on network assets for possible undesirable activity, by applying a Bayesian-based framework to systematically analyze indicators associated with early stages of such activity. This approach dramatically reduces the processing overheads of monitoring. The benefits to the security operation include scalability to networks exceeding 1 billion devices, providing earlier visibility of risk and improving prioritization and decision-making in deploying countermeasures. CyberOwl is developing its minimum viable product and is looking for two or three strategic industry design partners for validation, verification, and further development. The ideal design partner would provide access to real-world security problems in a large network, high-volume data environment.CyberOwl was founded on 2016 and is headquartered in London, England.
  • Kelda Technology — Kelda Technology is a British clean tech business that develops water-in-air shower products that halve water usage and water heating costs through patented shower technology. Kelda Technology has adapted cutting edge automotive and aerospace technology to produce a revolutionary “water-in-air” shower system that halves water use without any lossin performance. Water is broken into droplets to form a comfortable spray which is accelerated using a globally patented jet-type nozzle. Not only does it halve water costs, but also halves associated heating costs.The Kelda shower system holds appeal for a wide range of sectors, including gym and leisure, hotels and accommodation providers, healthcare, and maritime – all industries where water efficiency is key. The product has completed in-market validation and commercial trials, is in manufacture and the company has already signed installation deals with some of the largest leisure operators in the UK and Latin America.Kelda Technology was recently chosen as one of the top 30 cleantech companies in the world at the New Energy Start-Up awards 2016 and was this week shortlisted by the UK Business Angels Association for Best Investment in a Disruptive Tech Business.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 7 investments in United Kingdom Life Science startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $65k–$936k; Series A $1.8M–$4.1M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
  • Acea Health — Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .
  • Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 7 investments in United Kingdom Life Science startups

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Grant
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 285
  • Round size: Seed $300k–$3.4M; Grant $104k–$4.1M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • TileBio
  • Sentinel
  • Orbital Marine Power — Orbital Marine Power is an innovative Scottish engineering company focused on the development of a low-cost, predictable, scalable floating tidal technology.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 50
  • Round size: Seed $1.8M–$17M; Series A $17M–$110M; Series B $24M–$131M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
  • Purespring Therapeutics — A precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
IQ Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 7 investments in United Kingdom Life Science startups

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 183
  • Round size: Seed $1.3M–$12M; Series A $4.5M–$19M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Molyon — Molyon is creating the next-generation energy storage system: the lithium-sulfer battery. Molyon offers long-life lithium-sulfur batteries that have twice the energy density of existing lithium-ion batteries on the market.
  • Nyobolt — Nyobolt develops high-power energy storage systems based on advanced lithium-ion battery technology designed for rapid charging and sustained high performance. The company focuses on battery systems that enable very fast energy replenishment, supporting applications where downtime needs to be minimized. Its technology combines specialized anodematerials, cell design, battery management systems, and power electronics to achieve high charge and discharge rates. The platform is used in sectors such as robotics, data centers, industrial equipment, and electric mobility where consistent high power delivery is required. It also develops integrated energy solutions that support demanding workloads like automated logistics systems and high-performance computing infrastructure. Nyobolt’s approach emphasizes optimizing cycle life, thermal stability, and energy density for repeated fast charging environments.
  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 142
  • Round size: Seed $897k–$7.9M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • iFast Diagnostics — iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
  • Vitarka Therapeutics — Vitarka Therapeutics has engineered an intracellular drug delivery technology, EndoPore, using pore forming proteins for intracellular targets.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 6 investments in United Kingdom Life Science startups

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 84
  • Round size: Seed $1.3M–$2.9M; Series A $1.6M–$8.3M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
  • BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 103
  • Round size: Seed $196k–$3.9M; Series A $1.3M–$5.2M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Elemendar — Elemendar is building Artificial Intelligence that reads cyber threat reports by humans and turns them into industry-standard structured information.
  • NuVision — NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $458k–$880k
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
  • DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 108
  • Round size: Seed $1.5M–$16M; Series A $7.9M–$33M; Series B $13M–$73M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Hofy — Use Hofy's equipment management platform to remotely supply, manage and maintain subscription workstations, while staying compliant.
  • RobCo — Easily automate the repetitive tasks in your production facility with modular industrial robots from RobCo.
  • Paddle — The revenue engine powering payments for n8n, Letterboxd & AdGuard. One platform that handles subscription billing, payments and compliance.
Show all investments...

Selvedge Venture
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Singapore

Investor stats

  • Total investments: 13
  • Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 5 investments in United Kingdom Life Science startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 82
  • Round size: Seed $152k–$2.6M; Series A $2M–$15M
  • Lead/follow: 74% lead, 26% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
  • GeneralPractice.AI — General Practice. AI is an advanced, AI-powered platform designed to transform primary care and general practice by streamlining clinical workflows, enhancing patient engagement, and reducing administrative burdens for healthcare professionals. It aims to revolutionize primary care by harnessing artificial intelligence to improve both clinical andadministrative aspects of general practice, ultimately delivering more efficient, personalized, and effective healthcare.
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 5 investments in United Kingdom Life Science startups

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 57
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $5.2M–$28M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 5 investments in United Kingdom Life Science startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 47
  • Round size: Seed $531k–$8.5M; Series A $2.6M–$40M; Series B $2.4M–$55M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Leucid Bio — CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
  • Ryme Medical — Ryme Medical is a device company developing a novel catheter-based treatment for COPD
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 5 investments in United Kingdom Life Science startups

Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 208
  • Round size: Seed $327k–$3.1M; Series A $1.6M–$7M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 4 investments in United Kingdom Life Science startups

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 97
  • Round size: Seed $3.9M–$23M; Series A $2M–$73M; Series B $8.5M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
  • Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
  • Forefront RF — Forefront RF tunable duplexer technology expands the accessibility of all mobile devices by unlocking SDR capabilities in the RFFE front end.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 159
  • Round size: Seed $2.2M–$13M; Series A $3.8M–$20M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Oviva — Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in London, England.
  • uMotif — uMotif provides the most modern eCOA/ePRO and eConsent platform designed to power clinical and real-world research.
  • Ophelos — Flexible repayments, with an empathetic approach. Discover how we can help you get debt-free on your terms and timescales.
Show all investments...

O2h Ventures
VC Fund · 4 investments in United Kingdom Life Science startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 39
  • Round size: Seed $655k–$7.9M; Series A $1.9M–$26M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Neurocentrx — Neurocentrx is a specialty pharma company, developing and in-licensing products in pain, palliative care, psychiatry and mood disorders.
  • Alevin Therapeutics — Our mission is to develop safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies
Show all investments...

Angels 5K
VC Fund · Winchester, Hampshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $79k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
  • Novastone Media — Novastone enables instant chat across mobile and web to move customer conversations from email. Novastone’s white label chat solutions, built by financial industry experts, deliver on all these requirements, seamlessly moving organisations’ most valuable relationships from the inbox into a chat conversation.
  • Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
Show all investments...

Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 4 investments in United Kingdom Life Science startups

Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 146
  • Round size: Seed $183k–$3.5M; Pre-Seed $410k–$1.6M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Liopa — Liopa deciphers speech from lip movements alone; automated, AI-based lipreading to assist with speech recognition and voice technologies.
  • BrainWaveBank — BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populationsor demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments.BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
  • Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 188
  • Round size: Seed $393k–$7.6M; Series A $2M–$23M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2014

Portfolio highlights

  • Lumai — Lumai delivers optical compute for the inference era, enabling up to 50x AI performance and 90% less power. Supports billion-parameter LLMs today.
  • AudioScenic — THE NEW DIMENSION IN SOUND
  • Intrinsic Semiconductor Technologies — Exciting new developments around the Internet of Things, Big Data, autonomous vehicles, and Artificial Intelligence highlight how our approach to computation must fundamentally change.
Show all investments...

Playfair Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Playfair is a sector agnostic fund focused exclusively on pre-seed investing. Based in London, Playfair invests across the UK and Europe with an intentionally high conviction, low volume approach: making six investments a year out of its third $70m fund and preserving time, capital and resource to help companies post-investment. Our 78% Series Agraduation rate is ~3x industry average. Playfair has backed 100+ companies since 2013, including Thought Machine, Orca AI, Protex AI, StackOne and Nory.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 132
  • Round size: Seed $1M–$7.7M; Pre-Seed $700k–$3.1M; Series A $2.7M–$20M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Nory — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
  • Cauldron — Cauldron aim is to create a Worldbuilding is the art form that is foundational to everything at Cauldron. We want people to truly feel they can not only escape into our worlds, but through the advances of Web3, be a part of them.
  • Passionfruit — Join hundreds of the best startups around the world and use Passionfruit to hire freelance marketing specialists on-demand.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Biopharma
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 39
  • Round size: Seed $1.3M–$12M; Series A $17M–$61M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Show all investments...

Dementia Discovery Fund
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 49
  • Round size: Seed $5.9M–$20M; Series A $7M–$77M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $337M in 2018

Portfolio highlights

  • QurAlis — QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
  • Nitrase Therapeutics — Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
  • Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SR One
VC Fund · Cambridge, Massachusetts, United States · 4 investments in United Kingdom Life Science startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 182
  • Round size: Series A $3.7M–$87M; Series B $15M–$114M; Series C $22M–$115M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Turning Point Therapeutics — The Investor Relations website contains information about Turning Point Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
  • Spero Therapeutics — Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterialinfections. Spero’s lead program addresses a novel target driving virulence and persistence of Pseudomonas Aeruginosa infections and other Gram-negative pathogens. The company was founded by Atlas Venture, with financing from SR One and the Partners Innovation Fund.
  • Constellation Pharmaceuticals — Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Show all investments...

Maven Capital Partners
VC Fund · Glasgow, Glasgow City, United Kingdom · 4 investments in United Kingdom Life Science startups

Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 186
  • Round size: Seed $655k–$5.2M; Series A $2.6M–$25M
  • Lead/follow: 74% lead, 26% follow

Portfolio highlights

  • XR Games — XR Games (based in Leeds, England) makes both console and mobile Virtual and Augmented Reality (VR/AR) games for world famous Intellectual Properties. XR Games is an innovative start-up with Venture Capital funding.
  • Novatus Global — Novatus helps Financial Services Firms to Lead, Solve and Redefine with our expert Technology and Consulting Solutions.
  • Alderley Lighthouse Labs — Alderley Lighthouse Labs is a laboratory-based testing facility, specializing in human diagnostics.
Show all investments...

11.2 Capital
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1M–$12M; Series A $7.3M–$26M; Series B $15M–$53M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Human Security — HUMAN is a cybersecurity company that protects enterprises from bot attacks to keep digital experiences human.
  • CryptoNumerics — HIPAA, GDPR and Data Residency requirements restrict your ability to conduct data science. CryptoNumerics removes these restrictions. CryptoNumerics enables you to create privacy protected datasets with quantifiable privacy risk. In addition, you can build statistical and machine learning models that protect people’s privacy. Our team consists ofengineers and visionaries with previous experience in C-Level roles at Fortune 500 companies, founding teams of venture backed growth stage start-ups, and accomplished R&D leaders.
  • Coalesce Automation — Coalesce is the only data transformation tool built for scale. Evolve your transformations and empower your entire data team.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 4 investments in United Kingdom Life Science startups

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, France, Germany

Investor stats

  • Total investments: 245
  • Round size: Seed $1.2M–$10M; Series A $2.3M–$15M; Series B $4.2M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $66M in 2022

Portfolio highlights

  • Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
  • Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
  • Axelera AI — Axelera AI is developing a game-changing hardware and software platform for AI.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AIhas R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
Show all investments...

Delin Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, Hungary

Investor stats

  • Total investments: 31
  • Round size: Seed $1.3M–$9.2M; Series A $5.1M–$30M; Series B $15M–$100M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
  • Penzilla — At Penzilla, we believe it's time to make corporate pension provision the way it really should be - simple. That's why we offer a solution that helps everyone get the maximum benefit from corporate pension options. Most importantly, we enable every employer to achieve true corporate social responsibility with 100% compliance and everyemployee to receive a fair pension. This is how corporate pension provision works with Penzilla: Let's "Simply Provision" together.
  • Swarm Oncology — Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 4 investments in United Kingdom Life Science startups

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 189
  • Round size: Seed $39k–$1.8M; Series A $851k–$9.7M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
  • NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
  • Moralbox
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 357
  • Round size: Seed $1.9M–$11M; Series A $3M–$21M; Series B $7.5M–$46M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — raised $101M in 2019

Portfolio highlights

  • CertiVox — CertiVox solutions deliver simple, powerful information security to all things Internet (mainframes, too!), protecting business and individual privacy through the cloud and at rest. CertiVox was founded in 2009 to provide technology and services based on a simple belief: that everyone deserves the right to secure their information exchangessimply and easily. CertiVox's leading-edge encryption, key management and identity management solutions are currently in use at hundreds of the world’s leading corporations and used by individuals across the globe to protect their privacy.The companies passion is to create and share unique, cutting-edge cryptographic innovations for enterprise cloud computing and all things Internet. CertiVox are the only company in the global market today that has the technology in place to arm businesses and individuals with easy-to-use certificateless security solutions for any device and platform.Whether you are a business that wants to safeguard your company’s intellectual property, an ISV or SaaS provider that needs to embed cryptography and key management into your application, or an individual who wants to preserve the privacy of your personal data, CertiVox gives you the power to secure your information for all things Internet.CertiVox’s leading-edge solutions – including MIRACL (Multiprecision Integer and Rational Arithmetic C/C++ Library) Cryptographic SDK, on-demand encryption Key Management Service (KMS) and Identity Management Service (IDMS) – enable cloud service providers, independent software vendors (ISVs), communication providers, and smart device and semiconductor manufacturers to secure their voice and data communication solutions with ease.The PrivateSky Secure Information Exchange Service (SIX) gives individuals, businesses and their partners and customers easy-to-use tools to quickly encrypt email, files and documents without complex infrastructure or user burden. Compliance with mandatory encryption and privacy statues has never been easier.The bottom line: CertiVox's revolutionary certificateless cryptography, identity and key management solutions have taken the hassle out of Internet security, making it easy to securely exchange your information in any form, any time.
  • Mojo — Join 600,000+ men worldwide using AI-powered coaches to build a performance mindset and take back control of their love lives.
  • Phlux Technology — We develop, manufacture and supply innovative communication and vision components
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 133
  • Round size: Seed $196k–$2M; Series A $2M–$14M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • 4D Medicine
  • Adludio — Adludio is the AI-powered platform that delivers interactive mobile advertising. By using data to design your ad creative, and algorithms to optimize your campaigns, Adludio makes sure you win the battle for brand attention.
  • Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 4 investments in United Kingdom Life Science startups, 6 in the past 12 months

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 141
  • Lead/follow: no public data

Portfolio highlights

  • Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
  • Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
  • FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
Show all investments...

Google Ventures
VC Fund · Mountain View, California, United States · 4 investments in United Kingdom Life Science startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 983
  • Round size: Seed $1M–$13M; Series A $5.4M–$86M; Series B $15M–$105M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • Allara — Allara is your all-in-one virtual care team for hormonal, metabolic & gynecological conditions such as PCOS and Endometriosis.
  • Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
  • Merida Biosciences — Merida Biosciences is a new biotech company focused on developing precision treatments, particularly for autoimmune diseases. The company utilize a protein engineering platform to create unique Fc therapeutics, aiming to selectively bind to specific antibodies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SIS Ventures
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 3 investments in United Kingdom Life Science startups

SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$5.2M; Series A $2.8M–$19M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $1M in 2018

Portfolio highlights

  • Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
  • MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
  • Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Show all investments...

Molten Ventures
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

Molten Ventures is a leading British venture capital firm backing Europe’s highest-growth private technology companies. Our expert investment team stay ahead of the curve, identifying transformative trends and next-generation companies before they break through. We combine multiple pools of capital to invest at all stages of the businesslifecycle—from seed and early stage to growth and late stage—focusing on disruptive sectors like Spacetech, Fintech, and AI. Our strategy is simple: back bold ideas, scale them with capital and expertise, and unlock high-value exits—whether through strategic acquisitions, trade buy-outs, or IPOs. Since our 2016 IPO, we’ve delivered strong realised returns, reinvesting into the next wave of innovation—creating a virtuous cycle of growth and value.

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 219
  • Round size: Series A $3.2M–$30M; Series B $7.9M–$60M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: May invest from a new fund soon — raised $6.1M in 2011

Portfolio highlights

  • evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
  • DisplayLink — DisplayLink develops hardware and software solutions to enable easy connectivity between monitors, virtual reality HMDs and computing devices over standard interfaces such as USB, Ethernet, and wireless networks. DisplayLink’s enterprise technology increases productivity and ease-of-use in the multi-display workspace and is deployed to millions ofusers through globally branded PC products. DisplayLink’s XR solution enables a fully immersive, cable-free experience for virtual reality users.
  • ieso — View the homepage for ieso.
Show all investments...

Calculus Capital
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 71
  • Round size: Seed $2M–$18M; Series A $2.6M–$9.2M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
  • Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

Cambridge Angels group
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 3 investments in United Kingdom Life Science startups

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 130
  • Round size: Seed $270k–$2.9M; Series A $2M–$9.5M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • FLIT — Unfold Your Next Adventure. Discover the compact folding electric bike purpose-built for commuters, urban explorers and weekend tourers.
  • Wilder Sensing — Wilder Sensing analyses audio and other data sources to produce actionable insights into the status and trends of biodiversity on your site.
  • AVIEL Intelligence — Prevent APP fraud with the highest quality of intelligence. Use AVIEL intelligence to help prevent your customers making payments to scammers - and from receiving payments related to scams.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 3 investments in United Kingdom Life Science startups

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 80
  • Lead/follow: no public data

Portfolio highlights

  • Datamonk — AI-powered PACS migration platform that automates secure and fast transfers of medical imaging data. Migrate up to 10TB per day and use AI agents for data validation and quality assurance.
  • io Health — Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare.
  • Sober Sidekick — Gamified peer to peer support
Show all investments...

HG Ventures
VC Fund · Indianapolis, Indiana, United States · 3 investments in United Kingdom Life Science startups

Partnering with innovative, high-growth companies that support a sustainable future in materials, infrastructure, environmental solutions and industrial systems.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Renewable Energy
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 43
  • Lead/follow: no public data

Portfolio highlights

  • ZwitterCo — ZwitterCo is revolutionizing water & wastewater treatment with cutting-edge membrane technology, along with providing sustainable, high-efficiency solutions.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
  • PinPoint Analytics — Bring your construction estimating process into the 21st century! We deliver comprehensive insights into every project line item with real-time pricing data, leveraging hundreds of factors including weather patterns, market conditions, and historical trend analysis.
Show all investments...

Ada Ventures
VC Fund · London, England, United Kingdom · 3 investments in United Kingdom Life Science startups

Ada Ventures is a venture capital fund, backed by entrepreneurs and a group of global, mission-aligned investors. The fund invests in overlooked founders and overlooked markets. Ada Ventures is named after Ada Lovelace, the pioneering computer programmer, and mathematician, who was never recognized during the time she lived for what shecontributed to the advancement of technology and science.

Show more...

Investment focus

  • Industry: Health Care, Marketplace, Software
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland

Investor stats

  • Total investments: 41
  • Lead/follow: no public data

Portfolio highlights

  • Huboo — Introducing eCommerce order fulfilment the easy way: we take your stock, store it, pick, pack and deliver it for you automatically.
  • HACE — HACE is a specialist data company focused on the sustainable eradication of child labour in corporate supply chains. Our flagship product, the Child Labour Index (CLI), sold into Financial Services, scores and benchmarks a global universe of companies based on their exposure to child labour risk. Powered by AI, with transparency at its core, theCLI provides comprehensive data on company-specific risks relating to corporate governance frameworks and associated public sentiment, alongside generic supply chain risks affecting industry sectors. With an estimated 160 million children involved in child labour, this is a growing, stand-alone human rights and ESG risk issue for companies and investors, warranting dedicated attention. HACE’s data provides greater transparency around this risk, helping companies and their investors engage in better informed dialogue through the Stewardship Toolkit within the Child Labour Index. HACE is a female-founded business with significant experience in child labour risk management. Our commitment is to help our clients minimise their business and investment risks whilst making a difference around this major social challenge.
  • Polari Group — Polari Group believes the sexual health and wellness market should cater for everyone and that the next sexual revolution will be in anorectal health. Currently it takes up to 1 hour to prepare for anorectal intercourse, using a method called anal douching. This prevents spontaneity, affects romantic relationships, and increases the chances ofgetting a sexually transmitted infection. Our team develops category-defining products to make the preparation for anorectal intercourse straightforward and sex spontaneous.
Show all investments...

Discovery Park
VC Fund · Sandwich, Kent, United Kingdom · 3 investments in United Kingdom Life Science startups

Discovery Park is a thriving UK science park offering state-of-the-art lab space to rent and modern offices in Kent.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Biopharma
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • BugBiome — At BugBiome, our mission is to create safer pest control solutions by harnessing natural microbiomes through our high-throughput screening platform.
  • BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 3 investments in United Kingdom Life Science startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 27
  • Lead/follow: no public data

Portfolio highlights

  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 3 investments in United Kingdom Life Science startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 104
  • Lead/follow: no public data

Portfolio highlights

  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Show all investments...

Life Science VC funding in United Kingdom at a glance

Stats across 441 deals from 492 investors.

492
investors
in United Kingdom Life Science startups
441
deals
in United Kingdom Life Science startups
$3.7M
median round
in United Kingdom Life Science startups
45%
lead investors
lead at least one round
30%
Seed
most common funding stage

Access all 492 VC funds in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 492 VC funds investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists